Nanostructured lipid carriers as a delivery system of biochanin A

References

• Atkinson C, Compston JE, Day NE, et al. (2004). The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 79:326–33
   PubMed Web of Science ®Google Scholar
• Bargoni A, Cavalli R, Caputo O, et al. (1998). Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats. Pharm Res 15:745–50
   PubMed Web of Science ®Google Scholar
• Bhandari R, Kaur IP. (2013). Pharmacokinetics, tissue distribution and relative bioavailability of isoniazid solid lipid nanoparticles. Int J Pharm 441:202–12
   PubMed Web of Science ®Google Scholar
• Cassady JM, Zennie TM, Chae YH, et al. (1988). Use of a mammalian cell culture benzo(a) pyrene metabolism assay for the detection of potential anticarcinogens from natural products: inhibition of metabolism by biochanin A, an isoflavone from Trifolium pratense L. Cancer Res 48:6257–61
   PubMed Web of Science ®Google Scholar
• Chedeaui P, San Miquel G, Hidalgo L, et al. (2008). Effect of Trifolium pratense-derived isoflavones on the lipid profile of postmenopausal women with increased body mass index. Gynecol Endocrinol 24:620–4
   PubMed Web of Science ®Google Scholar
• Chinsriwongkul A, Chareanputtakhun P, Ngawhirunpat T, et al. (2011). Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug. AAPS Pharm Sci Tech 13:150–8
   PubMed Web of Science ®Google Scholar
• Chirio D, Gallarate M, Peira E, et al. (2011). Formulation of curcumin-loaded solid lipid nanoparticles produced by fatty acids coacervation technique. J Mroencapsul 28:637–48
   Google Scholar
• Dai W, Zhang D, Duan C, et al. (2010). Preparation and characteristics of oridonin-loaded nanostructured lipid carriers as a controlled-release delivery system. J Microencapsul 27:234–41
   PubMed Web of Science ®Google Scholar
• Das S, Chaudhury A. (2011). Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS Pharmasci Tech 12:62–76
   PubMed Web of Science ®Google Scholar
• Florence AT. (1997). The oral absorption of micro-and nanoparticulates: neither exceptional nor unusual. Pharm Res 14:259–66
   PubMed Web of Science ®Google Scholar
• Haede H, Das M, Jain S. (2011). Solid lipid nanoparticles: an oral bioavailability enhancer vehicle. Expert Opin Drug Deliv 8:1407–24
   PubMed Web of Science ®Google Scholar
• Han HK, Lee BJ, Lee HK. (2011). Enhanced dissolution and bioavailability of biochanin A via the preparation of solid dispersion in vitro and in vivo evaluation. Int J Pharm 415:89–94
   PubMed Web of Science ®Google Scholar
• Harini R, Ezhumalai M, Pugalendi KV. (2012). Antihyperglycemic effect of biochanin A, a soy isoflavone, one steptozotocindiabetic rats. Eur J Pharmacol 676:89–94
   PubMed Web of Science ®Google Scholar
• Huang X, Chen YJ, Peng DY, et al. (2013). Solid lipid nanoparticles as delivery systems for Gambogenic acid. Colloids Surf B Biointerfaces 102:391–7
   PubMed Web of Science ®Google Scholar
• Howes JB, Sullivan D, Lai N, et al. (2000). The effects of dietary supplement with isoflavones from red clover on the lipoprotein profiles of post menopausal women with mild to moderate hypercholesterolaemia. Atherosclerosis 152:143–7
   PubMed Web of Science ®Google Scholar
• Jia LJ Zhang DR, Li ZY, et al. (2010). Preparation and characterization of silybin-loaded nanostructured lipid carriers. Drug Deliv 17:11–8
   PubMed Web of Science ®Google Scholar
• Kole L, Giri B, Manna SK, et al. (2011). Biochanin A, an isoflavon, showed antiproliferative and anti- inflammatory activities through the inhibition of iNOS expression, p38-MAPK and ATF-2 phosphorylation and blocking NFκB nuclear translocation. Eur J Pharmacol 25:8–15
   Google Scholar
• Lee MK, Lim SJ, Kim CK. (2007). Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles. Biomaterials 28:2137–46
   PubMed Web of Science ®Google Scholar
• Manjunath K, Reddy JS, Venkateswarlu V. (2005). Solid lipid nanoparticles as drug delivery systems. Methods Find Exp Clin Pharmacol 27:127–44
   PubMed Web of Science ®Google Scholar
• Mehnert W, Mader K. (2001). Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 47:165–96
   PubMed Web of Science ®Google Scholar
• Müller RH, Radtke M, Wissing SA. (2002). Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 54:131–55
   PubMed Web of Science ®Google Scholar
• Müller RH, Mader K, Gohla S. (2000). Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm 50:161–77
   PubMed Web of Science ®Google Scholar
• Müller RH, Sheqokar R, Keck CM. (2011). 20 years of lipid nanoparticles (SLN and NLC): present state of development and industrial application. Curr Drug Discov Technol 8:207–27
   PubMedGoogle Scholar
• Moon YJ, Morris ME. (2007). Pharmacokinetics and bioavailability of the bioflavonoid biochanin a: effects and quercetin and EGCG on bioavailability disposition in rats. Mole Pharm 4:865–72
   PubMed Web of Science ®Google Scholar
• Moon YJ, Sagawa K, Frederick K, et al. (2006). Pharmacokinetics and bioavailability of the isoflavone biochanin A in rats. AAPS J 8:433–42
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Ray S, Thakur RS. (2009). Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian J Pharm Sci 71:349–58
   PubMed Web of Science ®Google Scholar
• Pardeike J, Hommoss A, Müller RH. (2009). Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm 366:170–84
   PubMed Web of Science ®Google Scholar
• Silvander M. (2002). Steric stabilization of liposomes – a review. Progr Colloid Polym Sci 120:35–40
   Google Scholar
• Singh SP, Wahajuddin Ali MM, et al. (2010). High-throughput quantification of isoflavones, biochanin A and genistein, and their conjugates in female rat plasma using LC-ESI-MS/MS: application in pharmacokinetic study. J Sep Sci 33:3326–34
   PubMed Web of Science ®Google Scholar
• Yoon KN, Alam N, Lee KR, et al. (2011). Antioxidant and antityroinase activities of various extracts from the fruiting bodies of Lentinus lepideus. Molecules 6:2334–47
   Google Scholar
• Zur Muhlen A, Schwarz C, Mehnert W. (1998). Solid lipid nanoparticles (SLN) for controlled drug delivery – drug release and release mechanism. Eur J Pharm Biopharm 45:149–55
   PubMed Web of Science ®Google Scholar